BioNTech SE (ETR:22UA)
Germany flag Germany · Delayed Price · Currency is EUR
101.70
+6.60 (6.94%)
At close: Aug 21, 2026

BioNTech SE Cash Flow Statement

Millions EUR. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-1,686-1,136-665.3930.39,43410,293
Depreciation & Amortization
478.9185.3156.6183.4123.375.2
Loss (Gain) From Sale of Assets
-3.1-2.5-0.33.80.64.6
Asset Writedown & Restructuring Costs
197.5197.5141.4---
Loss (Gain) From Sale of Investments
-10.4-10.44.6175.5-24157.3
Stock-Based Compensation
70.480.9-53.6-714.856.880.5
Other Operating Activities
527.5603.5-596.3-781.6-315.21,110
Change in Accounts Receivable
1,7721,084387.75,3744,370-11,808
Change in Inventory
131.5177.974.581.962.9-438.4
Change in Accounts Payable
-798.6-723.8758.4118.985.71,516
Operating Cash Flow
679.7456207.75,37113,577889.7
Operating Cash Flow Growth
-119.55%-96.13%-60.44%1426.07%-

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-210.5-175.1-286.5-250.1-329.2-127.5
Sale of Property, Plant & Equipment
8.54.51.2-0.63.4
Cash Acquisitions
264.8186.3--336.9--20.8
Sale (Purchase) of Intangibles
-24.5-573.9-165.8-455.4-34.1-26.5
Investment in Securities
-1,139-1,910-1,630-5,912327.4-394.7
Investing Cash Flow
-1,100-2,469-2,081-6,955-35.3-566.1

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-6.7-0.30.8-
Long-Term Debt Repaid
--57.6-45.9-40.4-59.9-66.7
Net Debt Issued (Repaid)
23.3-50.9-45.9-40.1-59.1-66.7
Issuance of Common Stock
----110.5163.6
Repurchase of Common Stock
-129.2---738.5-986.4-
Other Financing Activities
-2-2----2.7
Financing Cash Flow
-107.9-52.9-45.9-778.6-1,41994.2

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-26.8-2714.8-14.560.164.7
Miscellaneous Cash Flow Adjustments
26.95.92.8164.8-0.5-
Net Cash Flow
-528.5-2,087-1,902-2,21112,182482.5

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
469.2280.9-78.85,12113,248762.2
Free Cash Flow Growth
----61.34%1638.15%-
Free Cash Flow Margin
17.71%9.79%-2.86%134.10%76.53%4.02%
Free Cash Flow Per Share
1.891.16-0.3321.1053.032.94
Levered Free Cash Flow
-249.56-1,098-548.24,13912,009-646.6
Unlevered Free Cash Flow
-240.63-1,089-537.644,14312,020-629.54

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
10.81113.55.421.512.2
Cash Income Tax Paid
26.8-3.8389.2482.94,2223,458
Change in Working Capital
1,105537.81,2215,5754,519-10,730